Showing posts with label Pharmaceutical. Show all posts
Showing posts with label Pharmaceutical. Show all posts

30 Jan 2015

U.S., Europe and Japan Orthopedic Soft Tissue Surgical Procedures Market Expected to Reach USD 10.2 Billion in 2020

The U.S., Europe and Japan orthopedic soft tissue surgical procedures market was valued at USD 7.3 billion in 2013 and is estimated to reach a market worth of USD 10.2 billion in 2020 growing at a CAGR of 4.9% from 2014 to 2020. The report on U.S., Europe and Japan orthopedic soft tissue surgical procedures market studies market size of rotator cuff repair, vaginal prolapse, lateral epicondylitis, achilles tendinosis repair, gluteal tendon repair and anterior cruciate ligament reconstruction (ACL). Rising number of sport related injuries coupled with growth of active aging population in the developed regions would boost the demand of orthopedic soft tissue surgeries. According to the American Academy of Orthopaedic Surgeons (AAOS) and the American Orthopaedic Society for Sports Medicine, over 150,000 anterior cruciate ligament (ACL) injuries occur each year in the U.S. alone. Additionally, introduction of high cost and innovative surgical repair products and increasing incidence of obesity have raised the demand of orthopedic surgeries thereby propelling market growth. For example, Biomet, Inc. launched JuggerKnotless Soft Anchor device in July 2014 which featured company’s all-suture anchor technology. 

Browse the full U.S., Europe and Japan Orthopedic Soft Tissue Surgical Procedures Market (Rotator Cuff Repair, Vaginal Prolapse, Lateral Epicondylitis, Achilles Tendinosis Repair, Gluteal Tendon/Trochanteric Bursitis Repair and Anterior Cruciate Ligament (ACL) Reconstruction): Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020 report at http://www.transparencymarketresearch.com/soft-tissue-repair-sports-medicine.html

This device enables the repair of rotator cuff damage with better restoration and high efficacy. Growing acceptance of minimally invasive soft tissue surgical techniques (arthroscopy procedures) has enabled the completion of soft tissue surgeries in shorter time with lesser complication rates. This factor is also increasing the uptake of soft tissue surgeries. However, asymptomatic nature of soft tissue surgeries and high threat from conservative therapy are anticipated to restrain the market growth.

Orthopedic Soft Tissue Surgical Procedures Market
In terms of various surgical procedures ACL reconstruction accounted for the largest share of the market in 2013. ACL reconstruction is also likely to retain its dominant position in the future as it is the most common knee injury that requires surgical intervention. Rising participation in sports such as football, basketball and others along with increasing number of patients opting for reconstructive surgeries due to introduction of minimally invasive surgeries would fuel the growth of this segment. Similarly, launch of bio-absorbable which nullifies the risk related to implant removal would also aid in increasing the market size for ACL reconstruction. The market of gluteal tendon repair accounted for the smallest share in 2013 owing to large pool of patients being treated by non-operative methods such as pain killers and steroid injection for this condition. 

Geographically, the U.S. orthopedic soft tissue surgical procedures market captured major market revenue in 2013 and is expected to dominate the market during the forecast period from 2014 to 2020. Rising population base, increasing urge to stay healthy among geriatric population and improving healthcare coverage would contribute towards the growth of orthopedic soft tissue surgical procedures in this region. The orthopedic soft tissue surgical procedures market in Europe is anticipated to grow at a CAGR of 4.7% due to increasing number of sports related injuries. According to “Injuries in the European Union” published by EuroSafe, sports related injuries accounted for around 14% of the total injuries in the European Union. Similarly, a survey conducted by the professionals in Europe in 2010 concluded that the annual prevalence of people consulting for shoulder pain was 2.4% in the U.K.; most of these were attributed to rotator cuff injuries. Thus, increasing incidences of soft tissue injuries would propel the market growth in this region.

The orthopedic soft tissue surgical procedures market is fragmented in nature and is dominated by players, namely Arthrex, Inc., Smith & Nephew, plc., DePuy Synthes, Inc., Stryker Corporation., CONMED Corporation, and ArthroCare Corporation. Of all these, Arthrex was identified as the largest player in this market in 2013 followed by Smith & Nephew and Depuy Synthes, Inc. 

For further inquiries or purchase the  report, please visit: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1768

The U.S., Europe and Japan orthopedic soft tissue surgical procedures market is segmented as follows:

U.S. Orthopedic Soft Tissue Surgical Procedures Market, by Indications
  • Rotator Cuff Repair
  • Vaginal Prolapse
  • Lateral Epicondylitis
  • Achilles Tendinosis Repair
  • Gluteal Tendon Repair
  • Anterior Cruciate Ligament (ACL) Reconstruction
Europe Orthopedic Soft Tissue Surgical Procedures Market, by Indications
  • Rotator Cuff Repair
  • Vaginal Prolapse
  • Lateral Epicondylitis
  • Achilles Tendinosis Repair
  • Gluteal Tendon Repair
  • Anterior Cruciate Ligament (ACL) Reconstruction
Japan Orthopedic Soft Tissue Surgical Procedures Market, by Indications
  • Rotator Cuff Repair
  • Vaginal Prolapse
  • Lateral Epicondylitis
  • Achilles Tendinosis Repair
  • Gluteal Tendon Repair
  • Anterior Cruciate Ligament (ACL) Reconstruction

28 Jan 2015

U.S. Vaccine Market Expected to Reach USD 17.3 Billion in 2020

The U.S. vaccine market was valued at USD 12.8 billion in 2013 and is expected to grow at a CAGR of 4.3% from 2014 to 2020, to reach an estimated value of USD 17.3 billion in 2020. Earlier, the only way to achieve immunity against a disease was through infection with the actual disease, which is known as naturally-acquired immunity. Today, a number of vaccines are available that are administered to boost immunity against various diseases. The U.S. Centers for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices (ACIP) recommends vaccination against many diseases including hepatitis A, hepatitis B, influenza, meningococcal, pneumococcal, human papillomavirus (HPV), polio, rabies, rotavirus, varicella and Japanese encephalitis, among others. The U.S. vaccine market is growing under the influence of factors such as rising awareness regarding vaccination through various governmental and non-profit organizations, extremely low risk of serious and fatal side effects associated with vaccines and burgeoning demand for adult vaccines. On the contrary, stringent regulatory approval process, high cost associated with new vaccine discovery and development, and burden of maintaining cold chain logistics to prevent loss of vaccine potency and efficacy are some major factors creating hindrance in the growth of vaccine market. 

Browse the full U.S. Vaccine Market (Human Vaccines: Hepatitis, Influenza, Meningococcal, Pneumococcal, HPV, Combination Vaccines; Animal Vaccines: Canine, Feline, Porcine, Bovine, Ovine, Poultry and Equine) - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 report at http://www.transparencymarketresearch.com/us-vaccine-market.html

U.S. Vaccine Market
The U.S. vaccine market is majorly segmented into human and animal vaccines. The market for U.S. human vaccines has been further classified into pediatric and adult vaccine markets. The pediatric vaccine market represented the larger segment by revenue in 2013. However, during the forecast period from 2014 to 2020, the market for adult vaccines is expected to expand at a higher CAGR than the pediatric vaccines market. One of the major reasons for this is the CDC’s recommendations to adults for immunization against several diseases such as flu, pneumococcal, meningococcal, HPV infection, chickenpox and hepatitis. The CDC’s recommendations to all U.S. citizens aged 6 months and older travelling abroad to be up-to-date on routine vaccines and travel vaccines, also contribute to the market growth of adult vaccines.

On the basis of different antigens, the U.S. human vaccine market is segmented into hepatitis, influenza, meningococcal, pneumococcal, HPV, combination vaccines, and others. Of these, the combination vaccines segment held the largest share by revenue in 2013, though meningococcal vaccines are likely to form the fastest growing segment during the forecast period. This is primarily due to the anticipated launch of pipeline products in this segment during the forecast period. The U.S. human vaccine market is dominated by five major vaccine manufacturers: GlaxoSmithKline plc, Sanofi, Pfizer Ltd, Merck & Co., Inc., and Novartis International AG. These players collectively accounted for more than 85% of the total market revenue in 2013.

The U.S. animal vaccine market has been broadly classified as companion and livestock vaccine markets. The companion animal vaccine market segment has been further categorized into canine and feline, while the livestock vaccines market segment has been divided into porcine, bovine, ovine, poultry and equine sub-segments. Within the livestock vaccine market, bovine vaccine market represented the largest segment in terms of revenue in 2013. However, during the forecast period between 2014 and 2020, the poultry vaccine market is expected grow at the highest rate. Zoetis, Inc., Merck & Co., Inc. (Merck Animal Health), Sanofi (Merial, animal health division of Sanofi) and Boehringer Ingelheim are the leading players in the U.S. animal vaccine market.

For further inquiries or purchase the  report, please visit: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=553

The U.S. vaccine market is segmented as follows:

U.S. Human Vaccine Market, by Type

  • Pediatric
  • Adult

U.S. Human Vaccine Market, by Antigen

  • Hepatitis (A & B)
  • Influenza
  • Meningococcal
  • Pneumococcal
  • Human Papillomavirus (HPV)
  • Combination Vaccines (DTaP, DTaP-Hep B-IPV, DTaP-IPV and DTaP-IPV)
  • Others

U.S. Animal Vaccine Market, by Animal Type

  • Companion Animal Vaccine Market
  • Canine
  • Feline
  • Livestock Vaccine Market
  • Porcine
  • Bovine
  • Ovine
  • Poultry
  • Equine

23 Apr 2014

Growth and factors of Drugs of Abuse Testing Market Trends 2013-2019

According to a new market report published by Transparency Market Research "Drugs of Abuse Testing Market (Sample Based Testing - Urine, Saliva and Hair Onsite and laboratory Testing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018" the global drugs of abuse testing market was valued at USD 2.6 billion in 2012 and is expected to grow at a CAGR of 4.8% from 2013 to 2018, to reach an estimated value of USD 3.4 billion in 2018.

Browse the full Drugs Abuse Testing  Market Report with TOC at http://www.transparencymarketresearch.com/drugs-abuse-testing-market.html

In various countries, government rules & regulations are supporting drugs of abuse testing market to grow, as they have outlined essential drug testing at workplace, such as in the US, Japan, Australia and the UK. As a result, this market is expected to grow at a CAGR of about 4.8% during 2013 - 2018.

Drugs of Abuse Testing Market

Some of the key driving factors for the drugs of abuse testing market are global rising consumption of illicit drugs, adoption of drug of abuse (DOA) testing at organizational level, increased production of illicit drugs and their trade and increasing death rates/road accidents due to drug abuse. However, the market faces some restraints such as social concerns associated with illicit drugs testing, legalization of various drugs, and economic volatility and cost concerns.

North America, including the US has the largest drugs of abuse testing market and is also the fastest growing drugs of abuse testing market. Some of the fastest growing markets for drugs of abuse testing are US, UK, Japan, Germany and other European countries. According to UNODC report 2013, number of illicit drug users is estimated to increase from 167 million in 2009 to 315 million people in 2011. This corresponds to 3.6% to 6.9% of global adult population and cannabis, opioids and opiates were most commonly used illicit drugs. In various countries, including America and Europe countries, organizations are conducting drug screening test at various levels, such as pre-employment screening, random drug/alcohol screening, post incident drug/alcohol screening and abstinence monitoring. In many countries, government rules & regulations are also supporting the growth of drugs of abuse testing market, as they have outlined essential drug testing at workplace, such as in the US, Japan, Australia and the UK. This has emerged as a key driver for the market.

Urine is the largest sample which is diagnosed in the drugs of abuse testing market and it is expected to grow at a CAGR of about XX% during 2013 - 2018. The other major samples for drugs of abuse testing are Saliva and Hair. Laboratory drug screening test requires a trained and skilled person to provide an accurate result and involves in-depth analysis. In laboratory screening test, usually the test is reconfirmed using gas chromatography/mass spectrometry or any other superior techniques to provide accurate results. On-site drug screening test gives results on the spot and it is generally preferred for those who take the drug test at home, workplace and educational institutions. The most common specimens used in on-site drug testing are urine, saliva and hair. Nowadays, commercially-available on-site screening test kits are usually designed for urine and saliva specimens only.

Roche Diagnostics is the leading player in the global drugs of abuse testing market. Other major players of drugs of abuse testing market include Quest Diagnostics, LabCorp, Alere and Abbott Laboratories and others.

The global drugs of abuse testing market is segmented as follows:
Drugs of Abuse Testing Market, By Sample
·         Urine
·         Saliva
·         Hair
Drugs of Abuse Testing Market, By Types
·         Laboratory Drug Test
·         On-site Screening Test
Drugs of Abuse Testing Market, by Geography
·         North America
·         US 
·         Europe
·         UK
·         Germany
·         France
·         Asia Pacific
·         Japan
·         China
·         India
·         Rest of the World (RoW)

About Us:
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact:

Transparency Market Research
90 State Street,
Suite 700, Albany,NY – 12207,
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453

22 Apr 2014

Growth and factors of Endocrine Testing Market Share 2013-2019

Transparency Market Research is Published new Market Report "Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global endocrine testing market was valued at USD1.53billion in 2012 and is estimated to reach a market worth USD2.03 billion in 2019 growing at a CAGR of 4.3% from 2013 to 2019.

Browse Endocrine Testing Market Report with Full TOC at http://www.transparencymarketresearch.com/endocrine-testing-market.html

Endocrine system refers to the collection of endocrine glands (ductless glands) and secretory organs that release hormones directly into the blood stream. Endocrine system is instrumental in regulating certain body mechanisms such as metabolism, growth and sexual development and emotions. Also, it enables the body to cope up with different events such as cellular mechanisms and stress by acting in co-ordination with the nervous system. Hormones refer to the body's chemical messengers and render information and instruction transfer from one set of cells to another. Hormones can act only on those cells that are genetically programmed to receive and respond to the information or instructions released by hormones. There are lot of factors that influence the hormone levels including changes in body fluids and minerals in blood along with stress and infection.




Several endocrine tests are performed to assess varying levels of hormones in the body. This results in the determination of hypersecretion (excess) or hyposecretion (less) that consequently helps in early diagnosis and treatment of several endocrine disorders (such as sexual dysfunction, diabetes and others). Consistent rise in diabetic, obese and infertile patient population across the globe has broadened the scope for growth and acceptance of various endocrine test kits. In addition, introduction of technologically advanced diagnostic platforms coupled with growing healthcare awareness and surge in preference for quick and easy operating test platforms have further augmented the growth prospects for endocrine test kits or methodologies. On the contrary, high development costs and less flexible reimbursement policies are some of the factors that may hamper the growth of global endocrine testing market.

Endocrine tests are instrumental in monitoring the normal and abnormal levels of hormones secreted in the body. The market for insulin tests is estimated to record highest growth rate during the forecast period majorly due to increasing incidence of the diabetes worldwide coupled with technological advances and increasing healthcare awareness across the globe. As per International Diabetes Federation (IDF), in the year 2013, around 382 million people suffered from diabetes and are anticipated to rise to 592 million by 2035. Also, 80% of the diabetic population lives in low and middle income nations. Thyroid stimulating hormone test constituted the largest market segment owing to increasing thyroid dysfunction cases and pose high risk for acquiring cardiovascular disorders. The increased acceptance of endocrine test kits is attributed to increasing incidence of obesity, unhealthy food habits, physical inactivity and consistent technological advances. Follicle stimulating hormone test followed by human chorionic Gonadotropin test occupied third and fourth position in the market by 2019. Hence, all these factors mentioned above influence the growth and acceptance of several test kits.
Among the diagnostic technology market the tandem mass spectrometry segment is estimated to record highest growth rate due to high specificity and accuracy rendered by this platform in determination of hormone levels. Immunoassays and sensor technologies are expected to be the other fastest growing diagnostic technology segments during the forecast period owing to their increased use in several endocrine testing methodologies. However, high cost involved in the research and development along with subsequent commercialization of the same results in the high costs of the tests thereby hampering the growth of the market.

While, the ambulatory care centers of the total market, by end users segment  is expected to be the fastest growing segment during the forecast period due to quick service offerings and costs reduction due to less hospital stay and gain competitive edge over the other end users. In addition, home based tests and commercial laboratories are also expected to grow considerably as compared to others (hospitals and physician offices).

At the regional level, Europe was the largest market in 2012for endocrine testing market followed by North America. The growth has been attributed to the presence of sophisticated laboratories along with increased participation of the respective governments in these regions. Asia-Pacific region represents the fastest growing region during the forecast period from 2013 to 2019.This is majorly due to huge untapped patient population, increasing healthcare awareness and healthcare spending and presence of large number of undiagnosed and untreated patients in low and middle income nations. In addition, rise in disposable incomes and increased investments of many key players in these emerging economies will further boost the growth and development in this region. For instance, Abbott Laboratories has been investing heavily in the emerging economies such as India and China to enhance their revenues to 50% by 2015. The company has opened around six manufacturing and R&D facilities in Asia-Pacific region. This substantiates the lucrative business opportunities in these regions and enables the companies to introduce and commercialize quality endocrine tests thereby enhancing the strength of the market players.

The endocrine testing market is characterized by the presence of well-established as well as new players solely operating in this market. The major companies competing in this market are Agilent Technologies, F.Hoffmann La-Roche, Ltd., Abbott Laboratories and Siemens Healthcare and DiaSorin S.p.A.

The Global endocrine testing market is segmented as follows:

Endocrine TestingMarket, by Test
  • ·         Estradiol (E2) Test
  • ·         Follicle Stimulating Hormone (FSH) Test
  • ·         Human Chorionic Gonadotropin (hCG) Test
  • ·         Luteinizing Hormone (LH) Test
  • ·         Dehydroepiandrosterone sulfate (DHEAS) Test
  • ·         Progesterone Test
  • ·         Testosterone Test
  • ·         Thyroid Stimulating Hormone (TSH) Test
  • ·         Prolactin Test
  • ·         Cortisol Test
  • ·         Insulin Test
  • ·         Others (Gastrin, Thymosin, Secretin, etc.)
  • ·         Endocrine Testing Market, by Diagnostic Technologies
  • ·         Tandem Mass Spectrometry
  • ·         Immunoassay Technologies
  • ·         Monoclonal and Polyclonal Antibody Technologies
  • ·         Sensor Technologies
  • ·         Clinical Chemistry Technologies
  • ·         Others

Endocrine Testing Market, by End Users
  • ·         Hospitals
  • ·         Commercial Laboratories
  • ·         Ambulatory Care Centers
  • ·         Home Based Tests
  • ·         Physician Offices

Endocrine Testing Market, by Geography
  • ·         North America
  • ·         Europe
  • ·         Asia-Pacific
  • ·         Rest of the World (RoW)


About Us:
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact:

Transparency Market Research
90 State Street,
Suite 700, Albany,NY – 12207,
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453

 

Copyright @ 2015 Market Trends Reports.